Published in The Lancet Psychiatry · View the paper (DOI)
A randomized clinical trial found that prescribed doses of non-intoxicating CBD reduced cannabis use and increased abstinence days. Participants treated with 400mg or 800mg CBD showed lower levels of cannabis in their urine and more days abstinent compared to placebo.
Coverage from 2 institutions
- Prescribed CBD could help people quit cannabis University of Bath · Jul 28, 2020 · first to report
- The Lancet Psychiatry: First clinical trial of its kind studies whether cannabidiol could help treat cannabis use disorder, compared to placebo The Lancet · Jul 28, 2020